To introduce the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 for Indian drug law, pharmacy law, healthcare advertising, legal research and compliance study.
Overview #
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 is a central Indian legislation dealing with objectionable health-related advertisements. It does not primarily regulate the manufacture or sale of medicines; rather, it controls how drugs, alleged cures and so-called miraculous remedies are promoted to the public.
The Act targets advertisements that suggest the use of drugs for sensitive matters such as miscarriage, prevention of conception, sexual capacity, menstrual disorders and diseases or conditions specified in the statutory Schedule or rules. It also prohibits misleading advertisements relating to drugs and advertisements claiming efficacy of magic remedies for prohibited purposes.
The statute uses a wide meaning of advertisement, covering notices, circulars, labels, wrappers, documents and announcements made orally or by means producing or transmitting light, sound or smoke. It also defines drug broadly to include medicines, diagnostic or therapeutic substances, articles intended to affect the structure or organic functions of the body, and components of such items. A magic remedy includes talismans, mantras, kavachas, charms and similar items alleged to possess miraculous powers for diagnosis, cure, mitigation, treatment or prevention of disease.
Object of the legislation #
The object of the Act is to prevent public harm caused by exaggerated, false, exploitative or medically unsafe claims in relation to drugs and alleged magic remedies. Its legislative focus is on health advertising that may induce vulnerable persons to rely on unverified cures, delay timely medical consultation, or use products for conditions requiring proper medical diagnosis and treatment.
The Act therefore operates as a public health and consumer protection measure within the broader field of Indian drug regulation. It complements drug quality and licensing laws by regulating promotional claims and public communications about therapeutic efficacy.
Scope and relevance #
The Act is relevant to pharmaceutical companies, manufacturers, distributors, publishers, advertising agencies, digital marketers, healthcare businesses, traditional medicine advertisers, pharmacists and legal professionals advising on health product promotion. Because the definition of advertisement is broad, compliance analysis should not be limited to newspaper or television advertisements alone; labels, wrappers, circulars and other promotional communications may also require scrutiny.
For lawyers and legal researchers, the Act is important because it connects drug regulation with advertising liability, public health policy and misleading representation. For pharmacists and healthcare professionals, it is a key statute for understanding why some therapeutic, sexual health, reproductive health and disease-cure claims cannot be made in public-facing advertisements even where a product is otherwise sold in the market.
Selected important provisions and themes #
- Section 2 defines key expressions such as advertisement, drug, magic remedy, registered medical practitioner and taking part in publication of an advertisement.
- Section 3 prohibits advertisements referring to drugs in terms suggesting their use for specified purposes, including miscarriage, prevention of conception, sexual capacity, menstrual disorders and scheduled diseases or conditions.
- Section 4 prohibits misleading advertisements relating to drugs where the advertisement gives a false impression, makes a false claim or is false or misleading in any material particular.
- Section 5 prohibits advertisements by persons administering or purporting to administer magic remedies where efficacy is claimed for purposes covered by Section 3.
- Section 6 deals with import into, and export from, India of documents containing prohibited advertisements.
- Section 7 prescribes penalties for contravention of the Act or rules made under it, with higher exposure for subsequent conviction.
- Section 8, as reflected in the available text, concerns powers of entry, search and seizure by authorised Gazetted officers subject to rules.
- The Schedule and rule-making mechanism are central to identifying disease-related claims for which public advertisements are restricted.
How to use this Bare Act #
- Start with the definitions in Section 2 because the Act applies to many forms of communication and not only conventional advertisements.
- Read Sections 3, 4 and 5 together to distinguish prohibited disease-purpose advertisements, misleading drug claims and magic remedy claims.
- Check the Schedule and applicable rules before advising on any advertisement claiming diagnosis, cure, mitigation, treatment or prevention of a disease or disorder.
- Compare this Act with the Drugs and Cosmetics Act, 1940 to understand the difference between drug quality regulation and regulation of promotional claims.
- For compliance work, review product labels, wrappers, brochures, websites, social media creatives and scripts for objectionable claims.
Related Bare Acts and statutes #
- Drugs and Cosmetics Act, 1940 with Rules 1945
- Consumer Protection Act, 2019
- Food Safety and Standards Act, 2006
- Cosmetic Rules, 2020
This page is for legal education and statutory reference. The available PDF text may reproduce an older version of the Act, including older territorial or cross-reference language. Users should verify the latest amended text, rules, Schedule entries and official notifications before relying on the material for litigation, compliance or professional advice.
